Tech Company Financing Transactions
Nyxoah Funding Round
Nyxoah secured a $15 million venture capital round on 6/17/2026. Investors included European Investment Bank.
Transaction Overview
Company Name
Announced On
6/17/2026
Transaction Type
Debt
Amount
$15,000,000
Round
Undisclosed
Investors
Proceeds Purpose
This proceeds will allows us to accelerate the commercial launch of Genio in the United States while continuing to invest in innovation.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Rue Edouard Belin 12
Mont-Saint-Guibert, 1435
Belgium
Mont-Saint-Guibert, 1435
Belgium
Phone
Website
Email Address
Overview
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah's lead solution platform is based on the Genio® system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the world's most common sleep disordered breathing condition that is associated with increased mortality risk* and comorbidities including cardiovascular diseases, depression and stroke.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Olivier Taelman
Chief Financial Officer
Loïc Moreau
Chief Technical Officer
Bruno Onkelinx
VP - Marketing
Rémi Renard
Browse more venture capital transactions:
Prev: 6/17/2026: Convey AI venture capital transaction
Next: 6/17/2026: SandboxAQ venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs